Skip to main content
lexblog.com/lib/NG8MXYHQviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA and DEA approve CBD-based epilepsy medication",
    "url": "https://www.lexblog.com/2018/10/03/fda-and-dea-approve-cbd-based-epilepsy-medication/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-NG8MXYHQ",
        "url": "https://www.lexblog.com/lib/NG8MXYHQ/"
    },
    "datePublished": "2018-10-03T00:00:00-04:00",
    "dateModified": "2018-10-16T15:54:31-04:00",
    "author": {
        "@type": "Person",
        "name": "Marc J. Adesso"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Waller"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Waller Law Blogs",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "http://www.wallerlawblog.com/post/586/fda-and-dea-approve-cbd-based-epilepsy-medication",
    "sourceStability": "may-move"
}